ANGIODYNAMICS INC ANGO

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $15.88
Market Cap $653.03M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-3.8% YoY
$292.50M
3-Yr CAGR: -2.6%
Net Income ↑81.6% YoY
-$33.99M
Net Margin: -11.6%
Free Cash Flow ↑52.4% YoY
-$14.59M
FCF Yield: -2.23%
EPS (Diluted) ↑81.9% YoY
$-0.83
Basic: $-0.83
Return on Equity Efficiency
-18.6%
ROA: -451.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ANGO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $353.9M $174.3M $-43.6M $-1.21 $45.2M $42.9M
FY 2017 $349.6M -1.2% $176.2M $5.0M +111.5% $0.14 +111.6% $55.7M $52.7M +23.0%
FY 2018 $344.3M -1.5% $176.9M $16.3M +226.2% $0.44 +214.3% $41.3M $38.9M -26.3%
FY 2019 $270.6M -21.4% $156.0M $61.3M +275.5% $1.64 +272.7% $37.4M $34.3M -11.8%
FY 2020 $264.2M -2.4% $150.3M $-166.8M -371.9% $-4.39 -367.7% $-14.6M $-21.8M -163.5%
FY 2021 $291.0M +10.2% $156.8M $-31.5M +81.1% $-0.82 +81.3% $24.1M $18.9M +186.8%
FY 2022 $316.2M +8.7% $165.7M $-26.5M +15.9% $-0.68 +17.1% $-7.2M $-11.5M -160.8%
FY 2023 $338.8M +7.1% $174.2M $-52.4M -97.5% $-1.33 -95.6% $0.1M $-3.7M +67.5%
FY 2024 $303.9M -10.3% $154.7M $-184.3M -251.5% $-4.59 -245.1% $-28.2M $-30.7M -721.5%
FY 2025 $292.5M -3.8% $157.7M $-34.0M +81.6% $-0.83 +81.9% $-10.1M $-14.6M +52.4%
$

Valuation

Market Price $15.88
Market Cap $653.03M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 3.62
FCF Yield -2.23%
Dividend Yield N/A
Shares Outstanding 41,700,400
%

Profitability & Margins

Gross Margin 53.92%
Operating Margin -13.66%
Net Margin -11.62%
Return on Equity (ROE) -18.58%
Return on Assets (ROA) -451.13%
Asset Turnover 38.82x
Revenue 3-Yr CAGR -2.57%
🛡️

Financial Health & Liquidity

Current Ratio 0.21
Cash Ratio 1.57
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $55.89M
Total Debt N/A
Book Value / Share $4.39
💧

Cash Flow Efficiency

Operating Cash Flow -$10.13M
Capital Expenditures (CapEx) $4.46M
Free Cash Flow -$14.59M
OCF / Revenue -3.46%
FCF / Revenue -4.99%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.83
EPS (Basic) $-0.83
Dividends / Share N/A
Book Value / Share $4.39
EPS YoY Growth 81.92%
🏛️

Balance Sheet (FY 2025)

Total Assets $7.54M
Total Liabilities $35.52M
Stockholders' Equity $182.97M
Current Assets $7.54M
Current Liabilities $35.52M